Share on LinkedInShare on LinkedIn

ARTICLE · 19 OCTOBER 2015

Federal Circuit Patent Updates - October 2015

WilmerHale
WilmerHale
Contributor
WilmerHale

WilmerHale

WilmerHale's London office was established more than 40 years ago. With lawyers qualified in the...

View firm profile
Explore more from WilmerHale

Lourie, J. Affirming summary judgment that some claims are not infringed by ANDA submission. The patentee argued unsuccessfully that an aggregation of smaller doses could satisfy a claim limitation requiring at least two doses of 2000 mg.

United StatesIntellectual Property

View previous updates...

Spectrum Pharmaceuticals, Inc. v. Sandoz Inc. (No. 2015-1407, 10/2/15) (Lourie, Wallach, Hughes)

October 2, 2015 3:40 PM

Lourie, J. Affirming summary judgment that some claims are not infringed by ANDA submission. The patentee argued unsuccessfully that an aggregation of smaller doses could satisfy a claim limitation requiring at least two doses of 2000 mg. Also affirming decision that other claims are invalid. "This case is unusual in involving [a question of] whether a substantially pure compound would have been obvious when both the 50/50 mixture and the pure compound were known in the art. We agree with the district court that the claimed substantially pure compound would have been obvious over both the 50/50 mixture and the pure (6S) isomer compound in the prior art."

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from